Human CCL18/AMAC-1/AMAC1 ORF/cDNA clone-Lentivirus plasmid (NM_002988)

Cat. No.: pGMLP004613
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human CCL18/AMAC-1/AMAC1 Lentiviral expression plasmid for CCL18 lentivirus packaging, CCL18 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.


Target products collection

Go to CCL18/MIP-4/CCL18/AMAC-1 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Total Price: $450
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMLP004613
Gene Name CCL18
Accession Number NM_002988
Gene ID 6362
Species Human
Product Type Lentivirus plasmid (overexpression)
Insert Length 270 bp
Gene Alias AMAC-1,AMAC1,CKb7,DC-CK1,DCCK1,MIP-4,PARC,SCYA18
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGAAGGGCCTTGCAGCTGCCCTCCTTGTCCTCGTCTGCACCATGGCCCTCTGCTCCTGTGCACAAGTTGGTACCAACAAAGAGCTCTGCTGCCTCGTCTATACCTCCTGGCAGATTCCACAAAAGTTCATAGTTGACTATTCTGAAACCAGCCCCCAGTGCCCCAAGCCAGGTGTCATCCTCCTAACCAAGAGAGGCCGGCAGATCTGTGCTGACCCCAATAAGAAGTGGGTCCAGAAATACATCAGCGACCTGAAGCTGAATGCCTGA
ORF Protein Sequence MKGLAAALLVLVCTMALCSCAQVGTNKELCCLVYTSWQIPQKFIVDYSETSPQCPKPGVILLTKRGRQICADPNKKWVQKYISDLKLNA

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-SE0743-Ab Anti-CCL18/ AMAC-1/ AMAC1 functional antibody
    Target Antigen GM-Tg-g-SE0743-Ag CCL18 protein
    Cytokine cks-Tg-g-GM-SE0743 chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) (CCL18) protein & antibody
    ORF Viral Vector pGMLP004613 Human CCL18 Lentivirus plasmid
    ORF Viral Vector vGMLP004613 Human CCL18 Lentivirus particle


    Target information

    Target ID GM-SE0743
    Target Name CCL18/MIP-4
    Gene Group Identifier
    (Target Gene ID in Homo species)
    6362
    Gene ID 574181 (Macaca mulatta), 6362 (Homo sapiens)
    Gene Symbols & Synonyms CCL18,CKb7,PARC,AMAC1,DCCK1,MIP-4,AMAC-1,DC-CK1,SCYA18
    Target Alternative Names AMAC-1,AMAC1,Alternative macrophage activation-associated CC chemokine 1 (AMAC-1),C-C motif chemokine 18,CC chemokine PARC,CCL18,CKb7,DC-CK1,DCCK1,Dendritic cell chemokine 1 (DC-CK1),MIP-4,Macrophage inflammatory protein 4 (MIP-4),PARC,Pulmonary and activation-regulated chemokine,SCYA18,Small-inducible cytokine A18
    Uniprot Accession P55774,Q8HYP8
    Additional SwissProt Accessions: Q8HYP8,P55774
    Uniprot Entry Name
    Protein Sub-location Secreted Protein/Potential Cytokines
    Category Cytokine Target
    Disease Prostate Cancer, Malignant neoplasm of bladder, Overactive bladder
    Disease from KEGG Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, Chemokine signaling pathway
    Gene Ensembl ENSMMUG00000047114, ENSG00000275385
    Target Classification


    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.